Should steroids be administered for the treatment of achalasia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, steroids should not be given for achalasia.

Steroids are not a recognized or recommended treatment for achalasia and should not be used as therapy for this condition. The established first-line treatments are pneumatic dilation (PD), laparoscopic Heller myotomy (LHM), and peroral endoscopic myotomy (POEM) 1, 2.

Why Steroids Are Not Indicated

Achalasia is a primary esophageal motor disorder caused by degeneration of the myenteric plexus neurons, resulting in impaired lower esophageal sphincter (LES) relaxation and absent peristalsis 2. This is a structural neuromuscular problem, not an inflammatory condition that would respond to corticosteroids.

The pathophysiology requires mechanical disruption of the LES—either through dilation or myotomy—to relieve the outflow obstruction. No pharmacological treatments, including steroids, have proven effective for treating true achalasia 2.

The Exception That Proves the Rule

There is one isolated case report from 2011 describing a patient with manometric findings of achalasia who also had dense eosinophilic infiltration mimicking eosinophilic esophagitis 3. This patient responded to prednisolone 50 mg daily with complete resolution of symptoms and normalization of esophageal motility.

However, this represents a misdiagnosis rather than true achalasia treatment. This patient likely had eosinophilic esophagitis causing secondary esophageal dysmotility that mimicked achalasia manometrically. The response to steroids confirms this was an inflammatory condition (eosinophilic esophagitis), not idiopathic achalasia.

Proper Treatment Algorithm

When faced with manometric findings suggesting achalasia:

  • First, exclude secondary causes: Eosinophilic esophagitis, infiltrative diseases, cancer, or mechanical obstruction must be ruled out through endoscopy with biopsies, endoscopic ultrasound, or CT imaging 1

  • For confirmed idiopathic achalasia: Choose among the three established mechanical therapies based on:

    • Chicago Classification subtype (Type III benefits most from POEM with longer myotomy) 1
    • Patient preference and comorbidities
    • Local expertise availability 1
  • POEM is preferred for Type III achalasia when expertise is available, as the longer myotomy addresses the obstructive contractility of the distal esophagus 1

Critical Pitfall to Avoid

Do not mistake eosinophilic esophagitis with secondary dysmotility for true achalasia. If esophageal biopsies show dense eosinophilic infiltration (>15 eosinophils per high-power field), this suggests eosinophilic esophagitis as the primary diagnosis, which does respond to steroids or dietary elimination. True achalasia does not have significant eosinophilic infiltration and will not respond to anti-inflammatory therapy.

References

Research

Achalasia: Current therapeutic options.

Neurogastroenterology and motility, 2023

Research

Achalasia with dense eosinophilic infiltrate responds to steroid therapy.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.